Yale leaders in the field of geriatrics are focused on improving quality of life to match the increased life expectancy enjoyed by many Americans.
Researchers provide insights into the biological profiles of the underlying risk of substance use relapse, while treatment methods offer patients new options.
With its largest grant ever, Yale is assembling resources to help clinical scientists focus on ideas—and leave the red tape to others.
Demands for cures and a flat NIH budget are putting pressure on scientists to produce findings that go right to the bedside. Still, there's value in finding what you're not looking for.
After four years of research, an international effort finds that junk DNA may not be junk after all.
Despite a tougher climate for NIH dollars, school gets its largest grant ever as part of Roadmap initiative.